Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Glargine Replacing Oral Agents in T2DM
NCT00283049Phase 4Terminated
- Sponsor
- Sanofi
- Start
- Feb 2006
- Primary completion
- Nov 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Feb 2006; status: terminated.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00283049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00283049.